Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280747 · ClinicalTrials.gov registry record
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
A clinical trial, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Terminated
- Registry status
- 42
- Enrollment target
NCT01280747: Clinical Trial study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
NCT01280747 is a clinical trial that was terminated before completion, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01280747 was terminated before completion, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- TERMINATED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The investigators hypothesize that fibromyalgia (FM) and painful diabetic peripheral neuropathy (pDPN) patients with access restrictions on pregabalin will lead to higher healthcare resource use and cost compared to patients without such restrictions on pregabalin in a naturalistic setting. The randomization will occur at the physician level and not the patient level.
Interventions
- OTHER prior authorization
- OTHER no prior authorization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-04 |
Why NCT01280747 stopped before completion
NCT01280747 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which prior authorization is the first listed.
NCT01280747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01280747 about?
NCT01280747 is a clinical study titled "Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study". The investigators hypothesize that fibromyalgia (FM) and painful diabetic peripheral neuropathy (pDPN) patients with access restrictions on pregabalin will lead to higher healthcare resource use and cost compared to patients without such restrictions on pregabalin in a naturalistic setting. The rand...
What is the current status of trial NCT01280747?
This trial is currently terminated. The enrollment target is 42 participants. The study started on 2011-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01280747?
The interventions under investigation include: prior authorization (OTHER), no prior authorization (OTHER).
Who is sponsoring clinical trial NCT01280747?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia